Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Allometric-like scaling of AAV gene therapy for systemic protein delivery

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.10.011Source: DataRank Database

Allometric-like scaling of AAV gene therapy for systemic protein delivery is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0.449. It has been cited 19 times.

N/A

0.449DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.05)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.449

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (6)

Patrick Erickson ORCID,Raphaela Bento ORCID,Kariman Shama,Charles M. Roth ORCID,Biju Parekkadan ORCID

Live enrichment

PubMed:36381306 PMC:PMC9641010 OpenAlex:https://openalex.org/W4306977853

National Institutes of Health

Grant: R01EB012521

National Institutes of Health

Grant: R01EB028782

National Institutes of Health

Grant: 5R01EB028782-03

Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservation

National Institutes of Health

Grant: 1R01EB012521-01A1

Artificial, Humanized Stem Cell Niches

FWCI

3.05

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.omtm.2022.10.011

publisherhttps://doi.org/10.1016/j.omtm.2022.10.011

publisherhttps://api.elsevier.com/content/article/PII:S232905012200153X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S232905012200153X?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36381306

Fields of Study

Virus-based gene therapy researchRNA Interference and Gene DeliveryViral Infectious Diseases and Gene Expression in Insects0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

In vivoSteady state (chemistry)SecretionGenetic enhancementSecretory proteinIn vitroBiologyPharmacologyCell biologyComputational biologyChemistryGeneEndocrinologyBiochemistryGeneticsPharmacokineticsIn vivo ModelAav Gene TherapyModel Informed Drug DosingPredictive DosingQH573-671QH426-470Original ArticleCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being